PTC Therapeutics reported $239.04M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 178.32M 11.98M Sep/2026
Alnylam Pharmaceuticals USD 1.08B 172.17M Sep/2026
Amgen USD 10.35B 126M Sep/2026
BioCryst Pharmaceuticals USD 110.76M 3.94M Jun/2026
Biogen USD 2.38B 15.8M Sep/2026
BioMarin Pharmaceutical USD 1.08B 15.31M Sep/2026
Cytokinetics USD 24.43M 17.6M Jun/2026
Daiichi Sankyo JPY 700.97B 24.05B Sep/2026
Enanta Pharmaceuticals USD 40.16M 1.52M Dec/2024
Gilead Sciences USD 5.06B 314M Jun/2026
Incyte USD 1.24B 111.82M Sep/2026
Ionis Pharmaceuticals USD 88M 29.15M Sep/2026
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
Karyopharm Therapeutics USD 23.36M 2.82M Mar/2026
Novartis USD 9.96B 109M Sep/2026
Pfizer USD 17.57B 1.38B Sep/2026
PTC Therapeutics USD 239.04M 19.12M Jun/2026
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Roche Holding CHF 13.34B 1.44B Jun/2026
Sangamo BioSciences USD 581K 110K Jun/2024
Sarepta Therapeutics USD 385.98M 7.82M Sep/2026
TG Therapeutics USD 416.82M 15.26M Sep/2026
Ultragenyx Pharmaceutical USD 200M 140M Jun/2026
Vertex Pharmaceuticals USD 2.31B 176.7M Sep/2026
Xencor USD 42.23M 30.23M Jun/2026